+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Population Health Management Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 147 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797924
The global population health management market value was USD 31.2 billion in 2022, driven by the increase in ageing global population, and the rising cost of healthcare services across the globe. The market value is anticipated to grow at a CAGR of 16.9% during the forecast period of 2023-2031 to achieve a value of USD 126.6 billion by 2031.

Population Health Management Introduction

Population Health Management (PHM) is an emerging healthcare approach that aims to improve the health outcomes of a defined population while reducing the overall cost of healthcare. PHM encompasses a wide range of strategies, including health promotion, prevention, early intervention, care coordination, and the integration of data analytics to identify high-risk individuals and populations. By focusing on the health of an entire population, PHM seeks to address the social determinants of health and provide patient-centred care that is tailored to individual needs.

Population Health Management Market Scenario

In recent years, the global population health management market has witnessed significant growth, driven by factors such as the increasing prevalence of chronic diseases, an aging global population, and the rising cost of healthcare services. Governments, healthcare providers, and payers are increasingly adopting PHM strategies to improve patient outcomes, enhance the efficiency of healthcare systems, and control healthcare costs.

The adoption of population health management strategies has been increasing steadily due to factors such as the rising prevalence of chronic diseases, an aging global population, and the growing cost of healthcare services. Governments, healthcare providers, and payers are increasingly focusing on PHM to improve patient outcomes, enhance the efficiency of healthcare systems, and control healthcare costs.

North America: The largest market for population health management, driven by factors such as the high prevalence of chronic diseases, advanced healthcare infrastructure, and a strong focus on healthcare cost containment.

Europe: The second-largest market, with increasing demand for population health management solutions and a growing emphasis on improving healthcare outcomes and reducing healthcare costs.

Asia Pacific: Expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of chronic diseases, and growing awareness about the benefits of population health management strategies.

Population Health Management Market Segmentations

Market Breakup by Components

  • Software

Services

  • Post-Sale and Maintenance Services
  • Consulting Services
  • Training and Education Service
  • Implementation Services

Market Breakup by Mode of Delivery

  • On-Premises
  • Cloud Based

Market Breakup by End User

  • Healthcare Providers
  • Hospitals and Physician Groups
  • Ambulatory Care Centers
  • Healthcare Payers
  • Public
  • Private
  • Others

Market Breakup by Distribution Channels

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Key Trends in the Population Health Management Market

  • Technological advancements: The integration of advanced technologies such as big data analytics, artificial intelligence, machine learning, and the Internet of Things (IoT) is transforming the way healthcare providers identify high-risk individuals and populations, enabling targeted interventions and personalized care
  • Digital health solutions: The use of digital health solutions, such as telehealth, remote monitoring, and electronic health records, is playing a critical role in facilitating effective population health management by improving access to care, enhancing patient engagement, and promoting data-driven decision-making
  • Value-based care models: The shift towards value-based care models, which emphasize the quality of care and patient outcomes, is driving the adoption of population health management strategies and fostering collaboration among healthcare stakeholders

Population Health Management: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • MCKESSON CORPORATION
  • Verisk Analytics, Inc
  • Forward Health Group, Inc
  • Health Catalyst
  • Athenahealth, Inc
  • Cerner Corporation
  • Medecision
  • Xerox Corporation
  • Allscripts Healthcare, LLC
  • Fonemed
  • General Electric
  • HealthBI
  • NXGN Management, LLC
  • Optum Inc
  • Conifer Health Solutions, LLC
  • IBM
  • Koninklijke Philips N.V
  • Siemens Healthcare GmbH

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Population Health Management (PHM) Market Overview
3.1 Global Population Health Management (PHM) Market Historical Value (2016-2022)
3.2 Global Population Health Management (PHM) Market Forecast Value (2023-2031)
4 Global Population Health Management (PHM) Market Landscape
4.1 Global Population Health Management (PHM) Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Population Health Management (PHM) Product Landscape
4.2.1 Analysis by Components
4.2.2 Analysis by End User
4.2.3 Analysis by Mode of Delivery
5 Global Population Health Management (PHM) Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Population Health Management (PHM) Market Segmentation
6.1 Global Population Health Management (PHM) Market by Components
6.1.1 Market Overview
6.1.2 Software
6.1.3 Services
6.1.3.1 Post-Sale and Maintenance Services
6.1.3.2 Consulting Services
6.1.3.3 Training and Education Service
6.1.3.4 Implementation Services
6.2 Global Population Health Management (PHM) Market by Mode of Delivery
6.2.1 Market Overview
6.2.2 On-Premises
6.2.3 Cloud Based
6.3 Global Population Health Management (PHM) Market by End User
6.3.1 Market Overview
6.3.2 Healthcare Providers
6.3.3 Hospitals and Physician Groups
6.3.4 Ambulatory Care Centers
6.3.5 Healthcare Payers
6.3.6 Public
6.3.7 Private
6.3.8 Others
6.4 Global Population Health Management (PHM) Market by Distribution Channels
6.4.1 Market Overview
6.4.2 Hospitals Pharmacies
6.4.3 Retail Pharmacies
6.4.4 Online Pharmacies
6.4.5 Others
6.5 Global Population Health Management (PHM) Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Population Health Management (PHM) Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Population Health Management (PHM) Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Population Health Management (PHM) Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Population Health Management (PHM) Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Population Health Management (PHM) Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 MCKESSON CORPORATION
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Verisk Analytics, Inc
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Forward Health Group, Inc
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Health Catalyst
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Athenahealth, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Cerner Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Medecision
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Xerox Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Allscripts Healthcare, LLC
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Fonemed
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 General Electric
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 HealthBI
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 NXGN Management, LLC
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Optum Inc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Conifer Health Solutions, LLC
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 IBM
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Koninklijke Philips N.V.
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
17.18 Siemens Healthcare GmbH
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.18.5 Certifications
18 Global Population Health Management (PHM)-Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Mckesson Corporation
  • Verisk Analytics, Inc
  • Forward Health Group, Inc
  • Health Catalyst
  • Athenahealth, Inc.
  • Cerner Corporation
  • Medecision
  • Xerox Corporation
  • Allscripts Healthcare, LLC
  • Fonemed
  • General Electric
  • Healthbi
  • Nxgn Management, LLC
  • Optum Inc.
  • Conifer Health Solutions, LLC
  • Ibm
  • Koninklijke Philips N.V.
  • Siemens Healthcare Gmbh

Methodology

Loading
LOADING...

Table Information